Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Emergence of vanB Enterococcus gallinarum colonization in association with glycopeptide therapy.

Mahony AA, Huysmans MB, Liolios L, Faull JA, Boer JD, Spelman DW.

J Clin Microbiol. 2010 Jun;48(6):2319-20. doi: 10.1128/JCM.00222-10. Epub 2010 Mar 31. No abstract available.

2.
3.

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L.

Antimicrob Agents Chemother. 2006 Sep;50(9):2946-50.

4.

Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development.

Jenney AW, Clements A, Farn JL, Wijburg OL, McGlinchey A, Spelman DW, Pitt TL, Kaufmann ME, Liolios L, Moloney MB, Wesselingh SL, Strugnell RA.

J Clin Microbiol. 2006 Jan;44(1):102-7.

5.

Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients.

Cheng AC, Harrington G, Russo P, Liolios L, Spelman D.

Intern Med J. 2004 Aug;34(8):510-2.

PMID:
15317552
6.

Use of pulsed-field gel electrophoresis in infection control issues concerning Burkholderia cepacia.

Jenney A, Liolios L, Spelman D, Russo P, Wilson J, Wesselingh S, Kotsimbos T.

Infect Control Hosp Epidemiol. 2003 Aug;24(8):624-6.

PMID:
12940588
8.

Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis.

Michaelides A, Liolios L, Glare EM, Spelman DW, Bailey MJ, Walters EH, Williams TJ, Snell GI, Kotsimbos TC.

Transplantation. 2001 Jul 15;72(1):141-7.

PMID:
11468549
9.

Enterococcus durans vanB.

Jenney A, Franklin C, Liolios L, Spelman D.

J Antimicrob Chemother. 2000 Sep;46(3):515. No abstract available.

PMID:
10980186
10.

Cephalosporin clinical concentration-time profile modelling and in-vitro bactericidal effects on Escherichia coli.

Cholewka KA, Ioannides-Demos LL, Liolios L, Paull P, Spicer WJ, McLean AJ.

J Antimicrob Chemother. 1999 Oct;44(4):471-6.

PMID:
10588308
11.

Initial concentration-time profile of gentamicin determines efficacy against Enterobacter cloacae ATCC 13047.

Rayner CR, Ioannides-Demos LL, Brien JA, Liolios LL, Spicer WJ.

Antimicrob Agents Chemother. 1998 Jun;42(6):1370-4.

12.

Changes in MIC alter responses of Pseudomonas aeruginosa to tobramycin exposure.

Ioannides-Demos LL, Liolios L, Wood P, Spicer WJ, McLean AJ.

Antimicrob Agents Chemother. 1998 Jun;42(6):1365-9.

13.

Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentrations in patients with autoimmune diseases.

Ioannides-Demos LL, Christophidis N, Ryan P, Angelis P, Liolios L, McLean AJ.

J Rheumatol. 1997 Jan;24(1):49-54.

PMID:
9002010
14.

A prospective audit of total parenteral nutrition at a major teaching hospital.

Ioannides-Demos LL, Liolios L, Topliss DJ, McLean AJ.

Med J Aust. 1995 Sep 4;163(5):233, 235-7.

PMID:
7565206
15.

Concentration dependence of gentamicin post-bolus peak effect on Escherichia coli kill kinetics.

McLean AJ, Liolios L, Bastone EB, Ioannides-Demos LL, Spicer WJ, Christophidis N.

J Antimicrob Chemother. 1995 Mar;35(3):444-6. No abstract available.

PMID:
7782263

Supplemental Content

Loading ...
Support Center